Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Change in Cash (2016 - 2025)

Historic Change in Cash for Fresenius Medical Care AG (FMCQF) over the last 17 years, with Q3 2025 value amounting to -$542.3 million.

  • Fresenius Medical Care AG's Change in Cash fell 27936.01% to -$542.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$144.2 million, marking a year-over-year increase of 2710.41%. This contributed to the annual value of -$258.5 million for FY2024, which is 25657.51% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Change in Cash stood at -$542.3 million for Q3 2025, which was down 27936.01% from $726.1 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Change in Cash ranged from a high of $726.1 million in Q2 2025 and a low of -$542.3 million during Q3 2025
  • For the 5-year period, Fresenius Medical Care AG's Change in Cash averaged around $11.4 million, with its median value being -$53.6 million (2023).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Change in Cash tumbled by 345872.27% in 2022, and later soared by 94159.42% in 2025.
  • Fresenius Medical Care AG's Change in Cash (Quarter) stood at -$91.7 million in 2021, then soared by 278.23% to $163.5 million in 2022, then plummeted by 196.84% to -$158.3 million in 2023, then plummeted by 36.27% to -$215.7 million in 2024, then tumbled by 151.4% to -$542.3 million in 2025.
  • Its Change in Cash was -$542.3 million in Q3 2025, compared to $726.1 million in Q2 2025 and -$112.2 million in Q1 2025.